Colesevelam

This classification denotes an anti-lipidemic agent with the molecular formula (C13H27N)n.(C12H27ClN2)n.(C9H18N2O)n.(C3H7N)n, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1XU104G55N, chemically known as 1-hexaminium, n,n,n-trimethyl-6-(2-propenylamino)-, chloride, polymer with (chloromethyl)oxirane, 2-propen-4-amine and n-2-propenyl-1-decanamine, hydrochloride but generally known as colesevelam, which bears US NIH Compound Identifier 160051. European Medicines Agency schedules Colesevelam in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01423MIG. The term COLESEVELAM is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 12 No. 1 1998, List 39). World Health Organization schedules colesevelam in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule colesevelam under HS 39119099 and SITC 57596. As of Q4 2014, COLESEVELAM remains the US FDA Preferred Term for this commodity. Colesevelam bears US NLM identifiers UMLS ID C0541155 and NCI Concept Code C78056. SMILES: CCCCCCCCCCNCC=C.C[N+](C)(C)CCCCCCNCC=C.C=CCN.C1C(O1)CCl.Cl.[Cl-].